Compass Healthcare Communications Announces Relaunch of Infergen Web Site

Infergen, or consensus interferon, is a bio-optimized, selective and highly potent type 1 interferon alpha. It is indicated as a monotherapy for the treatment of adult patients suffering from chronic hepatitis C viral infections with compensated liver disease. Infergen is the only interferon with data in the label regarding use in patients following relapse or non-response to certain previous treatments. read more